1-3 of 3
Amy Keating
Close
Sort by
Journal Articles

Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias

Clinical Trials & Observations
Juan C. Fierro-Pineda, Hua-Ling Tsai, Amanda Blackford, Andrew Cluster, Emi Caywood, Jignesh Dalal, Jeffrey Davis, Maarten Egeler, Jeffrey Huo, Michelle Hudspeth, Amy Keating, Susan S. Kelly, Joerg Krueger, Dean Lee, Leslie Lehmann, Lisa Madden, Benjamin Oshrine, Michael A. Pulsipher, Terry Fry, Heather J. Symons
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5639–5648.
https://doi.org/10.1182/bloodadvances.2023010281
Published: 2023
Journal Articles

Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia

Michael R. Verneris, Qiufei Ma, Jie Zhang, Amy Keating, Ranjan Tiwari, Junlong Li, Hongbo Yang, Abhijit Agarwal, Lida Pacaud
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5387–5395.
https://doi.org/10.1182/bloodadvances.2020004045
Published: 2021
Journal Articles

Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma

Clinical Trials & Observations
Marcelo C. Pasquini, Zhen-Huan Hu, Kevin Curran, Theodore Laetsch, Frederick Locke, Rayne Rouce, Michael A. Pulsipher, Christine L. Phillips, Amy Keating, Matthew J. Frigault, Dana Salzberg, Samantha Jaglowski, Joshua P. Sasine, Joseph Rosenthal, Monalisa Ghosh, Daniel Landsburg, Steven Margossian, Paul L. Martin, Manali K. Kamdar, Peiman Hematti, Sarah Nikiforow, Cameron Turtle, Miguel-Angel Perales, Patricia Steinert, Mary M. Horowitz, Amy Moskop, Lida Pacaud, Lan Yi, Raghav Chawla, Eric Bleickardt, Stephan Grupp
Journal: Blood Advances
Blood Adv (2020) 4 (21): 5414–5424.
https://doi.org/10.1182/bloodadvances.2020003092
Published: 2020
Includes: Supplemental data